Medtronic (NYSE:MDT)'s fiscal Q2 2024 earnings call revealed mid-single-digit revenue growth, exceeding expectations with an adjusted EPS of $1.25. The growth was driven by...
By Khushi Mandowara and Christy Santhosh (Reuters) -Medtronic raised its annual earnings forecast on Tuesday as strong sales in its surgical and diabetes units allayed concerns...
Medtronic PLC (NYSE:MDT) reported a 5.3% increase in second-quarter fiscal year 2024 revenue, reaching $8 billion, driven by growth across its major business segments. Despite an...
Medtronic (NYSE:MDT)'s second-quarter earnings report revealed a significant increase in profits and a raised forecast for the full year following a robust performance that...
Investing.com - Medtronic (NYSE: MDT) reported second quarter EPS of $1.25, $0.07 better than the analyst estimate of $1.18. Revenue for the quarter came in at $8B versus the...
In a recent financial analysis, Whitbread (LON:WTB), known for its hospitality brands, has demonstrated financial efficiency with a return on capital employed (ROCE) of 7.2%,...
Johnson & Johnson (NYSE:JNJ)'s MedTech unit is planning to seek FDA clearance for its Ottava robotic surgical system in 2024, following delays caused by technical issues and...